Sign In
Buy STVN
$19.85
-0.350 (-1.73%)
At Close: Jul 31, 2026
Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for
11:05am, Tuesday, 22'nd Oct 2024
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CPRX or STVN: Which Is the Better Value Stock Right Now?
12:45pm, Monday, 21'st Oct 2024
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Catalyst Pharmaceutical (CPRX) and Stevanato Group (STVN). But which of these two stocks presents investor
CPRX or STVN: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 04'th Oct 2024
Investors interested in Medical - Drugs stocks are likely familiar with Catalyst Pharmaceutical (CPRX) and Stevanato Group (STVN). But which of these two stocks is more attractive to value investors?
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology and life sciences
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”
07:04am, Thursday, 26'th Sep 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology a
Stevanato Group to Present at Upcoming Investor Conferences
04:30pm, Thursday, 29'th Aug 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
SDZNY vs. STVN: Which Stock Is the Better Value Option?
12:47pm, Monday, 12'th Aug 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR (SDZNY) and Stevanato Group (STVN). But which of these two companies is the best option
Stevanato Group S.p.A. (STVN) Q2 2024 Earnings Call Transcript
09:09am, Saturday, 10'th Aug 2024
Stevanato Group S.p.A. (STVN) Q2 2024 Earnings Call Transcript
Stevanato Group (STVN) Q2 Earnings Match Estimates
08:50am, Tuesday, 06'th Aug 2024
Stevanato Group (STVN) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.15 per share a year ago.
Stevanato Group Reports Financial Results for the Second Quarter of 2024
06:31am, Tuesday, 06'th Aug 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group S.p.A. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - STVN
07:30am, Friday, 26'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stevanato Group S.p.A. ("Stevanato") (NYSE:STVN) concerning possible violation
STVN ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Stevanato Group S.p.A. Shareholders Who Lost Money
07:30am, Thursday, 25'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stevanato Group S.p.A. ("Stevanato") (NYSE:STVN) concerning possible violation
Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024
06:30am, Thursday, 25'th Jul 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology a
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stevanato Group S.p.A. ("Stevanato") (NYSE:STVN) concerning possible violation
NEW YORK, NY / ACCESSWIRE / July 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stevanato Group S.p.A. ("Stevanato") (NYSE:STVN) concerning possible violation
